Alcohol, the intoxicating chemical in the wine, is arguably notorious for its ill-health effects. But it’s not only the alcohol that makes wine a popular drink. In fact, it is loaded with a number of other chemicals that could work for a good health. Notably, resveratrol is most studied and is shown to be beneficial whether or not you have diabetes.
Red Wine Compound “Resveratrol” Keeps Blood Glucose In Check
Back in 2008, a study published in Endocrine, Metabolic and Immune Disorders Drug Targets revealed that resveratrol had protective effects against the metabolic syndrome and its complications. Metabolic syndrome is a cluster of factors that raise the risk of diabetes and stroke.
Likewise, a 2013 study published in The Review of Diabetic Studies found that resveratrol enhances the transportation of glucose from the bloodstream to the cells. Interestingly, the researchers also noted that such effect occurred even in the absence of insulin. Remember, reduced insulin levels or inability of the cells to utilize available insulin leads to hyperglycemia in diabetics.
[trendingtopicsrelated]
With such promising results, resveratrol has gained much attention in the scientific community. In fact, the recent human studies have further strengthened its role as a potential drug in diabetes management.
The latest to join the queue is a 2017 Danish study. Most importantly, this study included more than 70,000 men and women. This is a large number for scientific research. It concluded that a moderate intake, 3 to 4 times per week, could lower the risk of diabetes.
The Bottom Line
A wealth of study has explored the link between wine consumption and the risk of diabetes. Luckily, the results are encouraging. That said, you may take wine as per the doctor’s recommendations. In any case, make sure not to cross the weekly limits. Also, the researchers suggest the frequency of drinking is the key rather than the total amount you take.
Ready to raise a glass and not to raise your blood glucose?
[article1]
[expand title=”References“]
Endocrine, metabolic & immune disorders drug targets. URL Link. Retrieved July 28, 2017.
NIH. URL Link. Retrieved July 28, 2017.
The review of diabetic studies : RDS. URL Link. Retrieved July 28, 2017.
Diabetologia. URL Link. Retrieved July 28, 2017.
[/expand]
